How transplant surgeons can overcome the inevitable insufficiency of allograft size during adult living-donor liver transplantation: Strategy for donor safety with a smaller-size graft and excellent recipient results

Clinical Transplantation

Volumn 26, Issue 3, 2012, Pages

  Hori, Tomohide ^a   Ogura, Yasuhiro ^a   Ogawa, Kohei ^a   Kaido, Toshimi ^a   Segawa, Hajime ^a   Okajima, Hideaki ^a   Kogure, Takayuki ^b   Uemoto, Shinji ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Graft recipient weight ratio; Liver transplantation; Portal hypertension; Portal pressure; Shear stress; Small for size

Indexed keywords

INDOCYANINE GREEN;

ACUTE GRAFT REJECTION; ADULT; AREA UNDER THE CURVE; ARTICLE; ASCITES; ASPERGILLOSIS; AUTOIMMUNE HEPATITIS; BACTERIAL PERITONITIS; BLOOD CLOTTING DISORDER; BRAIN DISEASE; BRAIN HEMORRHAGE; BRAIN STEM INFARCTION; CANDIDIASIS; CEREBELLUM INFARCTION; CHRONIC GRAFT REJECTION; CYTOMEGALOVIRUS INFECTION; DIGESTIVE SYSTEM HEMORRHAGE; ENTEROSTOMY; EPSTEIN BARR VIRUS INFECTION; FEMALE; HEPATIC ARTERY THROMBOSIS; HEPATITIS C; HUMAN; INTESTINAL BLEEDING; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER SIZE; LIVER TRANSPLANTATION; LIVING DONOR; LIVING DONOR LIVER TRANSPLANTATION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PNEUMOCYSTIS PNEUMONIA; PORTAL HYPERTENSION; PORTAL VEIN BLOOD FLOW; PORTAL VEIN BLOOD PRESSURE; PORTAL VEIN THROMBOSIS; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPSIS; SPINAL CORD DISEASE; SPLENECTOMY; SURGEON; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; ORGAN SIZE; PATIENT SELECTION; PORTAL PRESSURE; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SPLENECTOMY; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84862256598     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2012.01664.x     Document Type: Article

References (27)

1. Inomata Y, Uemoto S, Asonuma K, Egawa H. Right lobe graft in living donor liver transplantation. Transplantation 2000: 69: 258.
2. Yamaoka Y, Washida M, Honda K et al. Liver transplantation using a right lobe graft from a living related donor. Transplantation 1994: 57: 1127.
3. Tanaka K, Inomata Y, Kaihara S. Living-Donor Liver Transplantation. Barcelona: Prous Science, 2003.
4. Takada Y, Ito T, Ueda Y et al. Effects of double-filtration plasmapheresis combined with interferon plus ribavirin for recurrent hepatitis C after living donor liver transplantation. Liver Transpl 2008: 14: 1044.
5. Kishi Y, Sugawara Y, Akamatsu N et al. Splenectomy and preemptive interferon therapy for hepatitis C patients after living-donor liver transplantation. Clin Transplant 2005: 19: 769.
6. Egawa H, Teramukai S, Haga H et al. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology 2008: 47: 143.
7. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994: 20: 15.
8. Iida T, Yagi S, Taniguchi K et al. Significance of CT attenuation value in liver grafts following right lobe living-donor liver transplantation. Am J Transplant 2005: 5: 1076.
9. ICG value, a reliable real-time estimator of graft function, accurately predicts outcomes in adult living-donor liver transplantation. Liver Transpl 2006: 12: 605.
10. Hori T, Yamamoto C, Yagi S et al. Assessment of cardiac output in liver transplantation recipients. Hepatobiliary Pancreat Dis Int 2008: 7: 362.
11. Hori T, Uemoto S, Takada Y et al. Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation? Surgery 2010: 147: 840.
12. Onaca NN, Levy MF, Netto GJ et al. Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transplant 2003: 3: 626.
13. Rana A, Hardy MA, Halazun KJ et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant 2008: 8: 2537.
14. Ghobrial RM, Steadman R, Gornbein J et al. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg 2001: 234: 384.
15. Eguchi S, Yanaga K, Sugiyama N et al. Relationship between portal venous flow and liver regeneration in patients after living donor right-lobe liver transplantation. Liver Transpl 2003: 9: 547.
16. Hori T, Yagi S, Iida T et al. Optimal systemic hemodynamic stability for successful clinical outcomes after adult living-donor liver transplantation: prospective observational study. J Gastroenterol Hepatol 2008: 23: e170.
17. Hori T, Yagi S, Iida T et al. Stability of cirrhotic systemic hemodynamics ensures sufficient splanchnic blood flow after living-donor liver transplantation in adult recipients with liver cirrhosis. World J Gastroenterol 2007: 13: 5918.
18. Yagi S, Iida T, Taniguchi K et al. Impact of portal venous pressure on regeneration and graft damage after living-donor liver transplantation. Liver Transpl 2005: 11: 68.
19. Ito T, Kiuchi T, Yamamoto H et al. Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications. Transplantation 2003: 75: 1313.
20. Ogura Y, Hori T, El Moghazy WM et al. Portal pressure < 15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before. Liver Transpl 2010: 16: 718.
21. Bosch J, Abraldes JG, Berzigotti A, Garcia-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009: 6: 573.
22. Burroughs AK. The natural history of varices. J Hepatol 1993: 17: S10.
23. Sainz-Barriga M, Scudeller L, Costa MG et al. Lack of correlation between portal vein flow and pressure: towards a shared interpretation of hemodynamic stress governing inflow modulation in LT. Liver Transpl 2011: 17: 836.
24. Levesque E, Saliba F, Benhamida S et al. Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation. Liver Transpl 2009: 15: 1358.
25. Jalan R, Plevris JN, Jalan AR et al. A pilot study of indocyanine green clearance as an early predictor of graft function. Transplantation 1994: 58: 196.
26. Tsubono T, Todo S, Jabbour N et al. Indocyanine green elimination test in orthotopic liver recipients. Hepatology 1996: 24: 1165.
27. Schenk A, Hindennach M, Radtke A et al. Formation of venous collaterals and regeneration in the donor remnant liver: volumetric analysis and three-dimensional visualization. Transplant Proc 2009: 41: 2515.